159 related articles for article (PubMed ID: 29085371)
61. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.
Ling Y; Maile LA; Lieskovska J; Badley-Clarke J; Clemmons DR
Mol Biol Cell; 2005 Jul; 16(7):3353-64. PubMed ID: 15888547
[TBL] [Abstract][Full Text] [Related]
62. IL-10 suppresses CD2-mediated T cell activation via SHP-1.
Taylor A; Verhagen J; Akkoç T; Wenig R; Flory E; Blaser K; Akdis M; Akdis CA
Mol Immunol; 2009 Feb; 46(4):622-9. PubMed ID: 18952289
[TBL] [Abstract][Full Text] [Related]
63. Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition.
Schneider H; Rudd CE
Biochem Biophys Res Commun; 2000 Mar; 269(1):279-83. PubMed ID: 10694513
[TBL] [Abstract][Full Text] [Related]
64. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1.
Wu Y; Nadler MJ; Brennan LA; Gish GD; Timms JF; Fusaki N; Jongstra-Bilen J; Tada N; Pawson T; Wither J; Neel BG; Hozumi N
Curr Biol; 1998 Sep; 8(18):1009-17. PubMed ID: 9740800
[TBL] [Abstract][Full Text] [Related]
65. Decreased expression of Src homology 2 domain-containing protein tyrosine phosphatase 1 reduces T cell activation threshold but not the severity of experimental autoimmune myasthenia gravis.
Deng C; Wu B; Yang H; Hussain RZ; Lovett-Racke AE; Christadoss P; Racke MK
J Neuroimmunol; 2003 May; 138(1-2):76-82. PubMed ID: 12742656
[TBL] [Abstract][Full Text] [Related]
66. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
Nakamura K; Cambier JC
J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
[TBL] [Abstract][Full Text] [Related]
67. Concomitant deletion of Ptpn6 and Ptpn11 in T cells fails to improve anticancer responses.
Ventura PMO; Gakovic M; Fischer BA; Spinelli L; Rota G; Pathak S; Khameneh HJ; Zenobi A; Thomson S; Birchmeier W; Cantrell DA; Guarda G
EMBO Rep; 2022 Nov; 23(11):e55399. PubMed ID: 36194675
[TBL] [Abstract][Full Text] [Related]
68. Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis.
Liu X; Qu CK
J Signal Transduct; 2011; 2011():195239. PubMed ID: 21799948
[TBL] [Abstract][Full Text] [Related]
69. Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo.
Rota G; Niogret C; Dang AT; Barros CR; Fonta NP; Alfei F; Morgado L; Zehn D; Birchmeier W; Vivier E; Guarda G
Cell Rep; 2018 Apr; 23(1):39-49. PubMed ID: 29617671
[TBL] [Abstract][Full Text] [Related]
70. Spontaneous chondroma formation in CD2-Cre-driven Erk-deficient mice.
Shiokawa M; Lu X; Miyake Y; Ishikawa E; Pagès G; Pouysségur J; Ogata M; Yamasaki S
Int Immunol; 2017 Dec; 29(10):479-485. PubMed ID: 29106539
[TBL] [Abstract][Full Text] [Related]
71. Rotating Magnetic Field Mitigates Ankylosing Spondylitis Targeting Osteocytes and Chondrocytes via Ameliorating Immune Dysfunctions.
Han Y; Yang H; Hua Z; Nie S; Xu S; Zhou C; Chen F; Li M; Yu Q; Sun Y; Wei Y; Wang X
Cells; 2023 Mar; 12(7):. PubMed ID: 37048045
[TBL] [Abstract][Full Text] [Related]
72. The Cell-Specific Role of SHP2 in Regulating Bone Homeostasis and Regeneration Niches.
Zhang J; Ye C; Zhu Y; Wang J; Liu J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768520
[TBL] [Abstract][Full Text] [Related]
73. T cell-specific constitutive active SHP2 enhances T cell memory formation and reduces T cell activation.
Cammann C; Israel N; Frentzel S; Jeron A; Topfstedt E; Schüler T; Simeoni L; Zenker M; Fehling HJ; Schraven B; Bruder D; Seifert U
Front Immunol; 2022; 13():958616. PubMed ID: 35983034
[TBL] [Abstract][Full Text] [Related]
74. Protein tyrosine phosphatases in skeletal development and diseases.
Yang H; Wang L; Shigley C; Yang W
Bone Res; 2022 Jan; 10(1):10. PubMed ID: 35091552
[TBL] [Abstract][Full Text] [Related]
75. Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis.
Shao F; Liu Q; Zhu Y; Fan Z; Chen W; Liu S; Li X; Guo W; Feng GS; Yu H; Xu Q; Sun Y
Nat Commun; 2021 Nov; 12(1):6540. PubMed ID: 34764263
[TBL] [Abstract][Full Text] [Related]
76. SHP-2 deletion in CD4Cre expressing chondrocyte precursors leads to tumor development with wrist tropism.
McNamara JT; Huntington KE; Borys S; Jayasuriya CT; Brossay L
Sci Rep; 2021 Oct; 11(1):20006. PubMed ID: 34625577
[TBL] [Abstract][Full Text] [Related]
77. Activating Mutation of SHP2 Establishes a Tumorigenic Phonotype Through Cell-Autonomous and Non-Cell-Autonomous Mechanisms.
Dong L; Han D; Meng X; Xu M; Zheng C; Xia Q
Front Cell Dev Biol; 2021; 9():630712. PubMed ID: 33777940
[TBL] [Abstract][Full Text] [Related]
78. Modulation of TCR Signaling by Tyrosine Phosphatases: From Autoimmunity to Immunotherapy.
Castro-Sanchez P; Teagle AR; Prade S; Zamoyska R
Front Cell Dev Biol; 2020; 8():608747. PubMed ID: 33425916
[TBL] [Abstract][Full Text] [Related]
79. T cell receptor and cytokine signal integration in CD8
Brzostek J; Gautam N; Zhao X; Chen EW; Mehta M; Tung DWH; Chua YL; Yap J; Cho SH; Sankaran S; Rybakin V; Fu G; Gascoigne NRJ
Nat Immunol; 2020 Feb; 21(2):186-198. PubMed ID: 31932808
[TBL] [Abstract][Full Text] [Related]
80. SHP-2 in Lymphocytes' Cytokine and Inhibitory Receptor Signaling.
Niogret C; Birchmeier W; Guarda G
Front Immunol; 2019; 10():2468. PubMed ID: 31708921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
